784 filings
Page 14 of 40
10-Q
2020 Q2
CRVO
CervoMed Inc
Quarterly report
7 Aug 20
4:12pm
8-K
CRVO
CervoMed Inc
29 Jul 20
Diffusion Pharmaceuticals Receives FDA Guidance for International Phase 1b/2b COVID-19 Clinical Program with TSC
8:14am
8-K
CRVO
CervoMed Inc
7 Jul 20
Phase 1b dosing expected to begin this month
4:38pm
4
CRVO
CervoMed Inc
18 Jun 20
Diffusion Pharmaceuticals / Robert W Adams ownership change
4:53pm
4
CRVO
CervoMed Inc
18 Jun 20
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
4:53pm
4
Giles Mark T
18 Jun 20
Diffusion Pharmaceuticals / Mark T Giles ownership change
4:52pm
4
CRVO
CervoMed Inc
18 Jun 20
Diffusion Pharmaceuticals / ALAN G LEVIN ownership change
4:52pm
8-K
CRVO
CervoMed Inc
17 Jun 20
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
CRVO
CervoMed Inc
12 Jun 20
Dosing expected to begin in Q2 2020 with first data in Q3 2020
12:18pm
EFFECT
CRVO
CervoMed Inc
11 Jun 20
Notice of effectiveness
12:15am
424B3
CRVO
CervoMed Inc
8 Jun 20
Prospectus supplement
4:48pm
S-1/A
CRVO
CervoMed Inc
IPO registration (amended)
3 Jun 20
5:25pm
CORRESP
CRVO
CervoMed Inc
3 Jun 20
Correspondence with SEC
12:00am
UPLOAD
CRVO
CervoMed Inc
2 Jun 20
Letter from SEC
12:00am
8-K
CRVO
CervoMed Inc
1 Jun 20
Other Events
4:40pm
S-1
CRVO
CervoMed Inc
IPO registration
29 May 20
5:20pm
D
CRVO
CervoMed Inc
27 May 20
$750K in options / securities to be acquired, sold $750K, 4 investors
4:57pm
8-K
CRVO
CervoMed Inc
26 May 20
Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program
4:45pm
8-K
CRVO
CervoMed Inc
20 May 20
Other Events
5:27pm
8-K
CRVO
CervoMed Inc
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm